tirzepatide hair loss In this week's episode of the Evidence Based Podcast, I delve into a fascinating study from JAAD Case Reports, which explores the potential benefits of the diabetes drug terzepatide (Mounjaro, Zepbound) ( I think these statistics

Alogliptin: a review of its use in patients with type 2 diabetes mellitus

All prescribing authority remains with licensed clinicians, and the program does not function as an inperson clinic

When glucagon receptor agonism is layered on top of GLP-1 and GIP activity, the theory is that you are not just reducing caloric intake through appetite suppression you are also increasing the rate at which the body burns energy, particularly fat stored in the liver

However, rapid or significant weight changes can occasionally trigger mood episodes in susceptible individuals

Smoking, socioeconomic factors, and age-related cataract: the Singapore Malay Eye study

*DISCLAIMER: These statements have not been evaluated by the Food and Drug Administration